Bax:Bcl2 Cancer Research Results
Bax:Bcl2, Bax:Bcl2 ratio: Click to Expand ⟱
| Source: |
| Type: |
Bax and Bcl-2 are the major members of Bcl-2 family that play a key role in tumor progression or inhibition of intrinsic apoptotic pathway triggered by mitochondrial dysfunction.
Bax/Bcl-2 ratio is typically significantly lower in tumors.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
*DNAdam↓, *ROS↓, *Bax:Bcl2↓, *p‑NRF2↑, *HO-1↑, *neuroP↑, *MMP↑,
*MDA↓, *NF-kB↓, *p65↓, *TNF-α↓, *cl‑Casp3↓, *GSR↑, *GSH↑, *NRF2↑, *HO-1↑, *Bax:Bcl2↓, *antiOx↑, *Inflam↓,
*MMP↑, *Bax:Bcl2↓, *cl‑PARP↓, *i-antiOx↑, *mt-Apoptosis↓, *neuroP↑,
selectivity↑, Bax:Bcl2↓, Bcl-xL↓, BAX↑, MMP↓, Cyt‑c↑, TumCD↑,
*BioAv↓, GlucoseCon↓, LDH↓, PDK1 / PDPK1↓, Glycolysis↓, mt-OXPHOS↓, Bax:Bcl2↓, cl‑Casp3↑, cl‑Casp9↑, Apoptosis↑, Hif1a↓, ROS↑, *AntiDiabetic↑, *cardioP↑, *RenoP↑, *ROS↓, *NF-kB↓, *NLRP3↓, *Pyro↓, *antiPs↑, *IL6↓, *IL8↓, BioAv↑, BioAv↑, BioAv↑,
*hepatoP↑, *ROS↓, *PGC-1α↝, *NRF2↑, *HO-1↑, *NQO1↝, *Keap1↝, *GCLC↝, *GCLM↝, *NLRP3↓, *IL1β↓, *IL6↓, *TNF-α↓, *MIP2↓, *Bax:Bcl2↓, *cl‑Casp3↓, *Inflam↓, *Apoptosis↓,
*ALAT↓, *AST↓, *lipid-P↓, *GSH↑, *Bax:Bcl2↓, *proCasp3↓, *cl‑Casp3↓, *antiOx↑,
Showing Research Papers: 1 to 7 of 7
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
mt-OXPHOS↓, 1, ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
GlucoseCon↓, 1, Glycolysis↓, 1, LDH↓, 1, PDK1 / PDPK1↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1, BAX↑, 1, Bax:Bcl2↓, 2, Bcl-xL↓, 1, cl‑Casp3↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 1, TumCD↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
Hif1a↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 3, selectivity↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
LDH↓, 1,
Total Targets: 19
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2, i-antiOx↑, 1, GCLC↝, 1, GCLM↝, 1, GSH↑, 2, GSR↑, 1, HO-1↑, 3, Keap1↝, 1, lipid-P↓, 1, MDA↓, 1, NQO1↝, 1, NRF2↑, 2, p‑NRF2↑, 1, ROS↓, 3,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↑, 2, PGC-1α↝, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↓, 1, mt-Apoptosis↓, 1, Bax:Bcl2↓, 5, cl‑Casp3↓, 3, proCasp3↓, 1, Pyro↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↓, 1, cl‑PARP↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL1β↓, 1, IL6↓, 2, IL8↓, 1, Inflam↓, 2, MIP2↓, 1, NF-kB↓, 2, p65↓, 1, TNF-α↓, 2,
Protein Aggregation(tgid=19) ⓘ
NLRP3↓, 2,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 1, IL6↓, 2,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 1, antiPs↑, 1, cardioP↑, 1, hepatoP↑, 1, neuroP↑, 2, RenoP↑, 1,
Total Targets: 44
Scientific Paper Hit Count for: Bax:Bcl2, Bax:Bcl2 ratio
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:352 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page